Evaluation of Pharmaceutical Companies
5 Pages Posted: 15 Feb 2012
Date Written: April 8, 2010
Abstract
The present work has not the task of developing a discussion of the main methods and criteria in evaluating the company, but wants to focus on the evaluation of pharmaceutical companies. from a difference in size of pharmaceutical companies, we will focus on issues such time period, intangible assets, research and development costs, royalty.
Keywords: evaluation, pharmaceutical, valutazione aziendale, patent, intangible
JEL Classification: G30
Suggested Citation: Suggested Citation
Saravalle, Andrea, Evaluation of Pharmaceutical Companies (April 8, 2010). Available at SSRN: https://ssrn.com/abstract=2004224 or http://dx.doi.org/10.2139/ssrn.2004224
Do you have negative results from your research you’d like to share?
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.